Checking the samples
![From left, Seo Jung-jin, co-founder of Celltrion, and Kim Kang-lip, head of the Ministry of Food and Drug Safety, look at a sample of CT-P59, a coronavirus treatment candidate, at a Celltrion factory in Incheon on Monday. On Feb. 5, the ministry granted conditional approval for Celltrion to market its Covid-19 treatment.[YONHAP]](https://koreajoongangdaily.joins.com/data/photo/2021/02/08/d7592f11-0a46-4b35-ab82-8cfb15bde72f.jpg)
From left, Seo Jung-jin, co-founder of Celltrion, and Kim Kang-lip, head of the Ministry of Food and Drug Safety, look at a sample of CT-P59, a coronavirus treatment candidate, at a Celltrion factory in Incheon on Monday. On Feb. 5, the ministry granted conditional approval for Celltrion to market its Covid-19 treatment.[YONHAP]
with the Korea JoongAng Daily
To write comments, please log in to one of the accounts.
Standards Board Policy (0/250자)